Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
Viavi Solutions senior vice president Luke M. Scrivanich reported selling 10,693 shares of Common Stock in open-market transactions at $53 per share. These insider sales were disclosed on a Form 4 filing for Viavi Solutions (ticker VIAV).
VIAVI SOLUTIONS INC. President & CEO Oleg Khaykin reported open-market sales of company common stock. He sold 20,238 indirectly owned shares held by his spouse at a weighted average price of about $54.77 per share, reducing that indirect position to zero. He also sold 104,552 directly owned shares at a weighted average price of about $54.61 per share, and held 1,482,702 shares directly after these transactions.
VIAVI SOLUTIONS INC. executive vice president and chief marketing and strategy officer Paul McNab executed an open-market sale of 2,727 shares of Common Stock at $54.96 per share. After this transaction, he directly holds 15,471 shares of VIAVI common stock.
VIAVI SOLUTIONS INC. director Doug Gilstrap reported an open-market sale of company stock. On May 5, 2026, he sold 10,000 shares of Common Stock at $55.00 per share. After this transaction, he directly holds 55,766 shares of Viavi common stock.
VIAVI Solutions Inc.'s notice identifies Helen Khaykin Irrevocable Trust as proposing to sell 20,238 common shares, with an approximate sale date of May 5, 2026. The shares are listed as restricted stock acquired from the issuer on August 28, 2004; the notice gives an aggregate market value of $1,108,449.43. It also lists 233,907,870 common shares outstanding.
VIAV notice reports an affiliate sale filing under Form 144 for Common Stock consisting of 2,727 shares tied to performance shares, with the filing dated 05/05/2026. The filing also records prior dispositions of 3,551 shares on 03/02/2026 for $116,792.39. The broker/dealer listed is Morgan Stanley Smith Barney LLC and the securities trade on NASDAQ.
VIAVI Solutions Inc. officer and director Oleg Khaykin gave notice of a proposed sale of 104,552 common shares, with an aggregate market value of $5,709,919.29 and an approximate sale date of May 5, 2026. Five February sales are also listed for Oleg Khaykin, the Oleg Khaykin Irrevocable Trust and the Helen Khaykin Irrevocable Trust.
VIAVI Solutions Inc. (VIAV) director Richard E. Belluzzo gave notice of a proposed sale of 51,110 common shares, with an aggregate market value of $2,724,071.00 and an approximate sale date of May 4, 2026.
The notice also reports sales of 15,775 shares on February 18, 2026, for gross proceeds of $423,563.48, and 13,058 shares on February 17, 2026, for gross proceeds of $345,385.41.
VIAVI Solutions Inc. officer Kevin Siebert reported a planned sale of 8,255 common shares, with an approximate sale date of May 4, 2026. The notice lists an aggregate market value of $445,970.60 and names Morgan Stanley Smith Barney LLC as broker. Siebert also reported a March 2, 2026 sale of 7,264 common shares for gross proceeds of $252,632.48.